Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies

Rose P. Webster, Leslie Myatt

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.

Original languageEnglish (US)
Pages (from-to)1147-1155
Number of pages9
JournalProteomics - Clinical Applications
Issue number9
StatePublished - Sep 2007
Externally publishedYes


  • Preeclampsia
  • Pregnancy
  • Vascular

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies'. Together they form a unique fingerprint.

Cite this